TP53 and cancer: Although TP53, PTEN, and CDKN2A are considered recessive tumor-suppressor genes, and deletions are frequently related with mutations of the second allele, supporting the “two-hit” of cancer development [46], many studies have shown the effect of their inactivation by a heterozygous mutation or one allele loss on tumorigenesis [25].